Research Paper Volume 17, Issue 4 pp 982—993
Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation
Figure 2. Incidence of primary and secondary outcomes (propensity score-matched cohort). (A) Cardiovascular events. (B) Congestive heart failure. (C) Arteriosclerotic disease. (D) Cardiovascular death. The incidence of composite cardiovascular events, arteriosclerotic disease, congestive heart failure, and cardiovascular death within 5 years was significantly and numerically lower in the Xa-I group than in the non-Xa-I group. CI, confidence interval; HR, hazard ratio; Xa-I, Factor Xa inhibitor.